Skip to main content
. 2021 Jul 13;14:3185–3196. doi: 10.2147/JIR.S319213

Figure 3.

Figure 3

Correlation of serum GSDMD, IL-1ß and IL-18 levels with disease severity in cirrhosis patients. (A-C) ELISA analysis of serum levels of GSDMD (A), IL-1ß (B) and IL-18 (C) in liver cirrhosis patients with Child-Pugh classification A, B and C. (D-F) Correlation between serum GSDMD (D), IL-1ß (E) and IL-18 (F) with Child-Pugh score in liver cirrhosis patients. (G-I) Correlation between serum GSDMD (G), IL-1ß (H) and IL-18 (I) with APRI score in liver cirrhosis. (J-L) Distribution of GSDMD (J), IL-1ß (K) and IL-18 (L) in compensated and decompensated cirrhosis. *p<0.05; **p<0.01; ***p<0.001.

Abbreviation: Ns, no statistical significance.